List of Tables
Table 1. Global Meglumine Adenosine Cyclophosphate Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Meglumine Adenosine Cyclophosphate Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Meglumine Adenosine Cyclophosphate Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Meglumine Adenosine Cyclophosphate Injection Sales (K Doses) of Key Manufacturers (2020-2025)
Table 5. Global Meglumine Adenosine Cyclophosphate Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Meglumine Adenosine Cyclophosphate Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Meglumine Adenosine Cyclophosphate Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Meglumine Adenosine Cyclophosphate Injection Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Meglumine Adenosine Cyclophosphate Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Meglumine Adenosine Cyclophosphate Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Meglumine Adenosine Cyclophosphate Injection, Product Type & Application
Table 12. Global Key Manufacturers of Meglumine Adenosine Cyclophosphate Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Meglumine Adenosine Cyclophosphate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meglumine Adenosine Cyclophosphate Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Meglumine Adenosine Cyclophosphate Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Meglumine Adenosine Cyclophosphate Injection Sales by Region (2020-2025) & (K Doses)
Table 18. Global Meglumine Adenosine Cyclophosphate Injection Sales Market Share by Region (2020-2025)
Table 19. Global Meglumine Adenosine Cyclophosphate Injection Sales by Region (2026-2031) & (K Doses)
Table 20. Global Meglumine Adenosine Cyclophosphate Injection Sales Market Share by Region (2026-2031)
Table 21. Global Meglumine Adenosine Cyclophosphate Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Meglumine Adenosine Cyclophosphate Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Meglumine Adenosine Cyclophosphate Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Meglumine Adenosine Cyclophosphate Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Meglumine Adenosine Cyclophosphate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Meglumine Adenosine Cyclophosphate Injection Sales by Country (2020-2025) & (K Doses)
Table 27. North America Meglumine Adenosine Cyclophosphate Injection Sales by Country (2026-2031) & (K Doses)
Table 28. North America Meglumine Adenosine Cyclophosphate Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Meglumine Adenosine Cyclophosphate Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Meglumine Adenosine Cyclophosphate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Meglumine Adenosine Cyclophosphate Injection Sales by Country (2020-2025) & (K Doses)
Table 32. Europe Meglumine Adenosine Cyclophosphate Injection Sales by Country (2026-2031) & (K Doses)
Table 33. Europe Meglumine Adenosine Cyclophosphate Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Meglumine Adenosine Cyclophosphate Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Meglumine Adenosine Cyclophosphate Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Meglumine Adenosine Cyclophosphate Injection Sales by Region (2020-2025) & (K Doses)
Table 37. Asia Pacific Meglumine Adenosine Cyclophosphate Injection Sales by Region (2026-2031) & (K Doses)
Table 38. Asia Pacific Meglumine Adenosine Cyclophosphate Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Meglumine Adenosine Cyclophosphate Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Meglumine Adenosine Cyclophosphate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Meglumine Adenosine Cyclophosphate Injection Sales by Country (2020-2025) & (K Doses)
Table 42. Latin America Meglumine Adenosine Cyclophosphate Injection Sales by Country (2026-2031) & (K Doses)
Table 43. Latin America Meglumine Adenosine Cyclophosphate Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Meglumine Adenosine Cyclophosphate Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Meglumine Adenosine Cyclophosphate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Meglumine Adenosine Cyclophosphate Injection Sales by Country (2020-2025) & (K Doses)
Table 47. Middle East and Africa Meglumine Adenosine Cyclophosphate Injection Sales by Country (2026-2031) & (K Doses)
Table 48. Middle East and Africa Meglumine Adenosine Cyclophosphate Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Meglumine Adenosine Cyclophosphate Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Meglumine Adenosine Cyclophosphate Injection Sales (K Doses) by Type (2020-2025)
Table 51. Global Meglumine Adenosine Cyclophosphate Injection Sales (K Doses) by Type (2026-2031)
Table 52. Global Meglumine Adenosine Cyclophosphate Injection Sales Market Share by Type (2020-2025)
Table 53. Global Meglumine Adenosine Cyclophosphate Injection Sales Market Share by Type (2026-2031)
Table 54. Global Meglumine Adenosine Cyclophosphate Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Meglumine Adenosine Cyclophosphate Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Meglumine Adenosine Cyclophosphate Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Meglumine Adenosine Cyclophosphate Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Meglumine Adenosine Cyclophosphate Injection Price (US$/Dose) by Type (2020-2025)
Table 59. Global Meglumine Adenosine Cyclophosphate Injection Price (US$/Dose) by Type (2026-2031)
Table 60. Global Meglumine Adenosine Cyclophosphate Injection Sales (K Doses) by Application (2020-2025)
Table 61. Global Meglumine Adenosine Cyclophosphate Injection Sales (K Doses) by Application (2026-2031)
Table 62. Global Meglumine Adenosine Cyclophosphate Injection Sales Market Share by Application (2020-2025)
Table 63. Global Meglumine Adenosine Cyclophosphate Injection Sales Market Share by Application (2026-2031)
Table 64. Global Meglumine Adenosine Cyclophosphate Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Meglumine Adenosine Cyclophosphate Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Meglumine Adenosine Cyclophosphate Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Meglumine Adenosine Cyclophosphate Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Meglumine Adenosine Cyclophosphate Injection Price (US$/Dose) by Application (2020-2025)
Table 69. Global Meglumine Adenosine Cyclophosphate Injection Price (US$/Dose) by Application (2026-2031)
Table 70. AdvaCare Pharma Company Information
Table 71. AdvaCare Pharma Description and Business Overview
Table 72. AdvaCare Pharma Meglumine Adenosine Cyclophosphate Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. AdvaCare Pharma Meglumine Adenosine Cyclophosphate Injection Product
Table 74. AdvaCare Pharma Recent Developments/Updates
Table 75. Ruiyang Pharmaceutical Co. Ltd Company Information
Table 76. Ruiyang Pharmaceutical Co. Ltd Description and Business Overview
Table 77. Ruiyang Pharmaceutical Co. Ltd Meglumine Adenosine Cyclophosphate Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. Ruiyang Pharmaceutical Co. Ltd Meglumine Adenosine Cyclophosphate Injection Product
Table 79. Ruiyang Pharmaceutical Co. Ltd Recent Developments/Updates
Table 80. Wuxi Kaifu Pharmaceutical Co., Ltd Company Information
Table 81. Wuxi Kaifu Pharmaceutical Co., Ltd Description and Business Overview
Table 82. Wuxi Kaifu Pharmaceutical Co., Ltd Meglumine Adenosine Cyclophosphate Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. Wuxi Kaifu Pharmaceutical Co., Ltd Meglumine Adenosine Cyclophosphate Injection Product
Table 84. Wuxi Kaifu Pharmaceutical Co., Ltd Recent Developments/Updates
Table 85. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Company Information
Table 86. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Description and Business Overview
Table 87. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Meglumine Adenosine Cyclophosphate Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Meglumine Adenosine Cyclophosphate Injection Product
Table 89. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Recent Developments/Updates
Table 90. Shanghai Fudan Fuhua Pharmaceutical co. LTD Company Information
Table 91. Shanghai Fudan Fuhua Pharmaceutical co. LTD Description and Business Overview
Table 92. Shanghai Fudan Fuhua Pharmaceutical co. LTD Meglumine Adenosine Cyclophosphate Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. Shanghai Fudan Fuhua Pharmaceutical co. LTD Meglumine Adenosine Cyclophosphate Injection Product
Table 94. Shanghai Fudan Fuhua Pharmaceutical co. LTD Recent Developments/Updates
Table 95. Shandong Peking University High-Tech Huatai Pharmaceutical Co. Ltd Company Information
Table 96. Shandong Peking University High-Tech Huatai Pharmaceutical Co. Ltd Description and Business Overview
Table 97. Shandong Peking University High-Tech Huatai Pharmaceutical Co. Ltd Meglumine Adenosine Cyclophosphate Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. Shandong Peking University High-Tech Huatai Pharmaceutical Co. Ltd Meglumine Adenosine Cyclophosphate Injection Product
Table 99. Shandong Peking University High-Tech Huatai Pharmaceutical Co. Ltd Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Meglumine Adenosine Cyclophosphate Injection Distributors List
Table 103. Meglumine Adenosine Cyclophosphate Injection Customers List
Table 104. Meglumine Adenosine Cyclophosphate Injection Market Trends
Table 105. Meglumine Adenosine Cyclophosphate Injection Market Drivers
Table 106. Meglumine Adenosine Cyclophosphate Injection Market Challenges
Table 107. Meglumine Adenosine Cyclophosphate Injection Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Meglumine Adenosine Cyclophosphate Injection
Figure 2. Global Meglumine Adenosine Cyclophosphate Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Meglumine Adenosine Cyclophosphate Injection Market Share by Type: 2024 & 2031
Figure 4. 60mg/5ml Product Picture
Figure 5. 30mg/2ml Product Picture
Figure 6. Global Meglumine Adenosine Cyclophosphate Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Meglumine Adenosine Cyclophosphate Injection Market Share by Application: 2024 & 2031
Figure 8. Heart Failure
Figure 9. Myocarditis
Figure 10. Coronary Heart Disease
Figure 11. Global Meglumine Adenosine Cyclophosphate Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Meglumine Adenosine Cyclophosphate Injection Market Size (2020-2031) & (US$ Million)
Figure 13. Global Meglumine Adenosine Cyclophosphate Injection Sales (2020-2031) & (K Doses)
Figure 14. Global Meglumine Adenosine Cyclophosphate Injection Average Price (US$/Dose) & (2020-2031)
Figure 15. Meglumine Adenosine Cyclophosphate Injection Report Years Considered
Figure 16. Meglumine Adenosine Cyclophosphate Injection Sales Share by Manufacturers in 2024
Figure 17. Global Meglumine Adenosine Cyclophosphate Injection Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Meglumine Adenosine Cyclophosphate Injection Players: Market Share by Revenue in Meglumine Adenosine Cyclophosphate Injection in 2024
Figure 19. Meglumine Adenosine Cyclophosphate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Meglumine Adenosine Cyclophosphate Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Meglumine Adenosine Cyclophosphate Injection Sales Market Share by Country (2020-2031)
Figure 22. North America Meglumine Adenosine Cyclophosphate Injection Revenue Market Share by Country (2020-2031)
Figure 23. United States Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Meglumine Adenosine Cyclophosphate Injection Sales Market Share by Country (2020-2031)
Figure 26. Europe Meglumine Adenosine Cyclophosphate Injection Revenue Market Share by Country (2020-2031)
Figure 27. Germany Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Meglumine Adenosine Cyclophosphate Injection Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Meglumine Adenosine Cyclophosphate Injection Revenue Market Share by Region (2020-2031)
Figure 34. China Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Meglumine Adenosine Cyclophosphate Injection Sales Market Share by Country (2020-2031)
Figure 44. Latin America Meglumine Adenosine Cyclophosphate Injection Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Meglumine Adenosine Cyclophosphate Injection Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Meglumine Adenosine Cyclophosphate Injection Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Meglumine Adenosine Cyclophosphate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Meglumine Adenosine Cyclophosphate Injection by Type (2020-2031)
Figure 54. Global Revenue Market Share of Meglumine Adenosine Cyclophosphate Injection by Type (2020-2031)
Figure 55. Global Meglumine Adenosine Cyclophosphate Injection Price (US$/Dose) by Type (2020-2031)
Figure 56. Global Sales Market Share of Meglumine Adenosine Cyclophosphate Injection by Application (2020-2031)
Figure 57. Global Revenue Market Share of Meglumine Adenosine Cyclophosphate Injection by Application (2020-2031)
Figure 58. Global Meglumine Adenosine Cyclophosphate Injection Price (US$/Dose) by Application (2020-2031)
Figure 59. Meglumine Adenosine Cyclophosphate Injection Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
